The EPS beat is positive but the filing lacks guidance or operational detail—likely a modest positive reaction. Monitor the Goldman Sachs conference on June 8-10 for any strategic updates or product pipeline commentary.
Price Chart
Executive Summary
iRadimed reported Q1 2026 EPS of $0.49, beating consensus of $0.44 by 11.4%, with revenue of $20.4M in line with estimates. The beat extends a strong track record of EPS surprises, but the filing is a routine press release announcing conference attendance with no new financial guidance or material operational updates.
Key Financial Metrics
Key Facts
- Q1 2026 EPS of $0.49 beat consensus of $0.44 by 11.4%
- Revenue of $20.4M matched consensus estimates
- Press release primarily announces Goldman Sachs conference attendance, not earnings results
- No guidance changes or material business updates provided
Financial Impact
EPS beat of $0.05 (11.4%) on consensus of $0.44; revenue in line at $20.4M
Risk Factors
- No forward guidance provided limits visibility into future performance
- Conference attendance is routine and unlikely to be a catalyst
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 1 press release from GlobeNewswire.
| Document | Accession Number |
|---|---|
| PRESS-RELEASE Data (Synthetic) | press-3298473 |
Track record builds as more directional reports settle.
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Jul 31, 2026 12w ago | 8-K | $90.86 $84.63 | ▼ −6.86% | ▼ −9.31% | $84.63 (−6.86%) |
Jul 31, 2026 12w ago | Press Release | $90.86 $84.63 | ▼ −6.86% | ▼ −9.31% | $84.63 (−6.86%) |
Jul 24, 2026 13w ago | Press Release | $95.08 $87.65 | ▼ −7.81% | ▼ −11.52% | $84.63 (−10.99%) |
Jun 4, 2026 20w ago | Insider Cluster | $93.07 $86.38 | ▼ −7.19% | ▼ −11.19% | $84.63 (−9.07%) |
May 20, 2026 22w ago | Press Release | $90.40 $86.95 | ▼ −3.82% | ▼ −8.82% | $84.63 (−6.38%) |
May 1, 2026 25w ago | Press Release | $87.15 $94.83 | ▲ +8.81% | ▲ +5.74% | $84.63 (−2.89%) |
Apr 27, 2026 26w ago | Press Release | $89.08 $94.08 | ▲ +5.61% | ▲ +0.84% | $84.63 (−5.00%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers